Canadian Manufacturer Automates Sales Order Processing Between Salesforce and SYSPRO

bioLytical Laboratories deploys BPA Platform as a single integration solution for its business functions End Quote

(1888PressRelease) October 18, 2024 - Codeless Platforms today revealed that bioLytical Laboratories Inc., an industry leader in manufacturing rapid in vitro diagnostic tests, has integrated Salesforce with SYSPRO via BPA Platform to automate its sales order processing. BPA Platform is subsequently being used as the main, single integration solution to address a wide variety of its business functions.

“The key task that we initially addressed with BPA Platform was the integration of sales transactions between Salesforce and SYSPRO, the ERP system that is used throughout our manufacturing facility,” explained Steve Dillen, IT Director, bioLytical Laboratories Inc.

“We are currently adding BPA Platform modules and endpoint licenses to allow increased integration with our distribution channels, and continue to assess a number of different sales channels that we anticipate supporting with BPA Platform.”

bioLytical Laboratories discovered BPA Platform during initial assessment of WooCommerce and Shopify eCommerce solutions which included full SYSPRO integration. It was during this research that the company realised that BPA Platform also had connectors for Salesforce as well as a number of other platforms.

“While assessing potential eCommerce solutions, we were also seeking a tool that would provide improved integration between SYSPRO and Salesforce, as the tool that we had previously been using was reaching end of life. During the research, we determined that BPA Platform could address our Salesforce needs,” revealed Steve Dillen.

“The representation that BPA Platform is a very low-code solution with the flexibility to accommodate different levels of integration between the target platforms was an important consideration in our selection process. Another big factor for us was the variety of endpoints supported by the tool, allowing bioLytical to deploy a single integration solution that would address a wide variety of business functions.”

BPA Platform is now firmly established in bioLytical Laboratories’ technology stack and has become the default integration solution for all current and future SYSPRO projects.

“I think it’s a great solution. The flexibility and dynamic nature of the tool is the key benefit. If we have a business requirement to change how we are integrating an element of data, we can have that in place in a matter of minutes. BPA Platform has significantly improved our ability to respond to changing business requirements and to update our systems to address those requirements,” said Steve Dillen.

“At the end of the day, BPA Platform is a key component in bioLytical’s strategic solution for software integration with SYSPRO. We’ve been using it for over a year and a half and have found it to be rock stable. That’s very important to my team as it allows us to focus our effort on introducing new solutions while having high confidence in the reliability of execution.”

“Initial deployment resulted in similar core functionality using BPA Platform as we had previously with the benefit of increased flexibility in accommodating new business rules and integration solutions that we may need. The low-code approach has allowed our team to quickly define new solutions and to move those into production without delay.”

About bioLytical Laboratories Inc.
bioLytical Laboratories Inc. is an industry leader in manufacturing rapid in vitro diagnostic tests with a global mission to ensure every person has access to our tests to learn their status, faster. bioLytical’s flagship range of one-minute INSTI® tests provide immediate and accurate results for infectious diseases. By testing for antibodies specific to each disease, the INSTI® platform is scalable and adaptable to detect diseases such as HIV, Syphilis, Hepatitis C (HCV), and COVID-19. bioLytical continues to find ways to reach customers wherever they are. Starting with a rapid COVID-19 Antigen test, iStatis is the next evolution of the bioLytical testing lineup. With the vision to reach more people, iStatis was designed to be accessible and simple to use, offering high-quality tests with trusted results. One by one, with iStatis and INSTI®, bioLytical is leading a movement to remove barriers to infectious disease testing. Learn more at: https://biolytical.com

About Codeless Platforms
Codeless Platforms provides a powerful low-code platform that empowers global businesses to take full control of their data and accelerate business growth. Customers use our cutting-edge BPA Platform to create a fully integrated, streamlined ecosystem, automate business processes and synchronise their data. Since 1999, we have developed our flexible and scalable platform to help businesses easily respond to the rapidly changing business demands of today as well as prepare them for the future. With over 450 global partners, more than 7500 customers use Codeless Platforms’ software solutions. Learn more at: www.codelessplatforms.com

###

space

Other Related Press Releases